Keywords: sfda, grants, aoxing, license, opioid, dependence, drug

SFDA grants Aoxing R&D license for opioid dependence drug

Article | 26 November 2007

Shijiazhuang city-headquartered China Aoxing Pharmaceutical says that the State Food and Drug Administration has granted a license that allows it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Buprenex

Buprenorphine

Naloxone

Narcan

Go to drug listing